CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Other acquisition Chief Executive Officer acquired 248,735 shares (other)
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 3/A Insider 3/A
- D Other Notice of Sales of Unregistered Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Other acquisition Chief Executive Officer acquired 248,735 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Other acquisition Director acquired 5,828 shares (other)
- 4 Other acquisition Director acquired 5,828 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 10,002 shares (other)
Page 16 of 23 · 445 filings